• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Pres. and Rep. Director, ALIJ Koide Masatoshi sold $3,906,941 worth of shares (37,000 units at $105.59), decreasing direct ownership by 34% to 70,992 units (SEC Form 4)

    5/22/25 9:19:36 AM ET
    $AFL
    Accident &Health Insurance
    Finance
    Get the next $AFL alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Koide Masatoshi

    (Last) (First) (Middle)
    C/O AFLAC INCORPORATED
    1932 WYNNTON ROAD

    (Street)
    COLUMBUS GA 31999

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    AFLAC INC [ AFL ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director 10% Owner
    X Officer (give title below) Other (specify below)
    Pres. and Rep. Director, ALIJ
    3. Date of Earliest Transaction (Month/Day/Year)
    05/20/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 05/20/2025 S 37,000 D $105.593(1) 70,992 D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    1. The price is the weighted average sale price of the aggregate number of shares that were sold. These shares were sold in multiple transactions at prices ranging from $105.34 to $105.77. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
    Remarks:
    By: Brooke R. Phillips For: Masatoshi Koide 05/22/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $AFL alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $AFL

    DatePrice TargetRatingAnalyst
    1/23/2025$111.00Market Perform
    BMO Capital Markets
    10/9/2024$102.00Hold
    TD Cowen
    9/5/2024$96.00Underweight
    Barclays
    1/4/2024$76.00 → $78.00In-line → Underperform
    Evercore ISI
    8/18/2023$74.00 → $75.00Overweight → Equal-Weight
    Morgan Stanley
    6/5/2023$77.00Buy
    BofA Securities
    4/25/2023$73.00Equal Weight
    Wells Fargo
    5/24/2022$60.00Neutral
    Citigroup
    More analyst ratings

    $AFL
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • BMO Capital Markets initiated coverage on Aflac with a new price target

      BMO Capital Markets initiated coverage of Aflac with a rating of Market Perform and set a new price target of $111.00

      1/23/25 7:31:57 AM ET
      $AFL
      Accident &Health Insurance
      Finance
    • TD Cowen initiated coverage on Aflac with a new price target

      TD Cowen initiated coverage of Aflac with a rating of Hold and set a new price target of $102.00

      10/9/24 7:27:31 AM ET
      $AFL
      Accident &Health Insurance
      Finance
    • Barclays initiated coverage on Aflac with a new price target

      Barclays initiated coverage of Aflac with a rating of Underweight and set a new price target of $96.00

      9/5/24 8:02:01 AM ET
      $AFL
      Accident &Health Insurance
      Finance

    $AFL
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Lloyd Karole bought $77,280 worth of shares (1,000 units at $77.28), increasing direct ownership by 2% to 44,896 units (SEC Form 4)

      4 - AFLAC INC (0000004977) (Issuer)

      2/7/24 9:27:59 AM ET
      $AFL
      Accident &Health Insurance
      Finance
    • Bowers William P bought $114,000 worth of shares (1,500 units at $76.00), increasing direct ownership by 2% to 61,817 units (SEC Form 4)

      4 - AFLAC INC (0000004977) (Issuer)

      2/7/24 9:17:57 AM ET
      $AFL
      Accident &Health Insurance
      Finance

    $AFL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Pres. and Rep. Director, ALIJ Koide Masatoshi sold $3,906,941 worth of shares (37,000 units at $105.59), decreasing direct ownership by 34% to 70,992 units (SEC Form 4)

      4 - AFLAC INC (0000004977) (Issuer)

      5/22/25 9:19:36 AM ET
      $AFL
      Accident &Health Insurance
      Finance
    • Director Collins Arthur Reginald sold $290,689 worth of shares (2,750 units at $105.70), decreasing direct ownership by 29% to 6,728 units (SEC Form 4)

      4 - AFLAC INC (0000004977) (Issuer)

      5/19/25 9:24:36 AM ET
      $AFL
      Accident &Health Insurance
      Finance
    • Director Kenny Thomas J sold $762,238 worth of shares (7,168 units at $106.34), decreasing direct ownership by 36% to 12,954 units (SEC Form 4)

      4 - AFLAC INC (0000004977) (Issuer)

      5/13/25 4:39:43 PM ET
      $AFL
      Accident &Health Insurance
      Finance

    $AFL
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Aflac Incorporated Announces First Quarter Results, Reports First Quarter Net Earnings of $29 Million, Declares Second Quarter Dividend

      COLUMBUS, Ga., April 30, 2025 /PRNewswire/ -- Aflac Incorporated (NYSE:AFL) today reported its first quarter results. Total revenues were $3.4 billion in the first quarter of 2025, compared with $5.4 billion in the first quarter of 2024, primarily due to net investment losses of $963 million this quarter compared to net investment gains of $951 million in the first quarter of 2024. Net earnings were $29 million, or $0.05 per diluted share, compared with $1.9 billion, or $3.25 per diluted share a year ago. Net earnings in the first quarter of 2025 included net investment losses of $963 million, or $1.76 per diluted share, compared with net investment gains of $951 million, or $1.65 per dilute

      4/30/25 4:05:00 PM ET
      $AFL
      Accident &Health Insurance
      Finance
    • Aflac Incorporated to Release First Quarter Results and CFO Video Update on April 30, 2025 and Host Webcast on May 1, 2025

      COLUMBUS, Ga., April 3, 2025 /PRNewswire/ -- Aflac Incorporated (NYSE:AFL) announced today that it will release first quarter 2025 financial results after the market closes on April 30, 2025. At that time, earnings materials, including the quarterly earnings release and financial supplement, will be available, along with a financial update video from Senior Executive Vice President and Chief Financial Officer Max Brodén, on the company's Investor Relations website, investors.aflac.com. Aflac Incorporated will also webcast a conference call scheduled for 8:00 a.m. (ET) on Thurs

      4/3/25 4:05:00 PM ET
      $AFL
      Accident &Health Insurance
      Finance
    • Aflac and the American Cancer Society Team Up to encourage proactive health care and early detection

      Teams to focus on preventive wellness by addressing physical, emotional and financial toxicity related to a cancer diagnosis COLUMBUS, Ga., Feb. 25, 2025 /PRNewswire/ -- Aflac Incorporated (Aflac), the leading provider of cancer insurance in the United States and Japan, is teaming up with the American Cancer Society (ACS), the leading cancer-fighting organization with a vision of ending cancer as we know it — for everyone. Together, they will shine a light on the ways early cancer detection can support individuals as they navigate the physical, emotional and financial challenges associated with the disease, particularly as data from the most recent (2024) Aflac Wellness Matters Survey found

      2/25/25 8:00:00 AM ET
      $AFL
      Accident &Health Insurance
      Finance